managing-palliative-care-integration

name	managing-palliative-care-integration
description	Guides palliative care consultation timing and symptom management integration with curative therapy. Use when integrating palliative care, managing cancer symptoms, or coordinating concurrent curative and palliative treatment.
tags	["management","oncology","treatment"]
metadata	{"author":"casemark","practice_areas":["Medical Oncology","Hematology-Oncology","Radiation Oncology"],"document_types":["Management Report"],"skill_modes":["Management","Coordination"]}

Managing Palliative Care Integration

Guides palliative care consultation timing and symptom management integration with curative therapy.

Why This Skill Exists

The landmark Temel et al. study (NEJM, 2010) demonstrated that early palliative care integration in metastatic NSCLC improved survival by 2.7 months compared to standard oncologic care alone. ASCO published a provisional clinical opinion in 2012 (updated 2017) stating that combined standard oncology care and palliative care should be considered early in the course of illness for patients with metastatic cancer and/or high symptom burden. Despite this evidence, palliative care is still frequently initiated only at end of life.

NCCN Palliative Care guidelines recommend palliative care consultation for any patient with serious illness, significant symptom burden, or distress regardless of disease stage. CMS quality measures and CoC standards increasingly incorporate palliative care referral metrics. Late palliative care referral is associated with higher healthcare costs, more aggressive end-of-life care, decreased quality of life, and worse caregiver bereavement outcomes.

---

Checkpoint A: Pre-Draft Intake (Mandatory)

1. What is the patient's cancer diagnosis, stage, and prognosis? (Default: [VERIFY])
2. What is the current treatment intent (curative, disease-directed with palliative intent, comfort-focused)? (Default: specify)
3. What is the patient's current symptom burden? (Default: use Edmonton Symptom Assessment System or ESAS)
4. Has a palliative care consultation been requested or initiated? (Default: assess appropriateness)
5. What is the patient's understanding of their prognosis? (Default: assess illness understanding)
6. Has advance care planning been initiated (advance directive, healthcare proxy, POLST/MOLST)? (Default: assess status)
7. What is the patient's psychosocial and spiritual distress level? (Default: use NCCN Distress Thermometer)
8. Are there caregiver support needs? (Default: assess)

Documents to Request

• Current symptom assessment (ESAS, numerical rating scales)
• NCCN Distress Thermometer screening results
• Current medication list including all symptom management medications
• Advance directive and healthcare proxy documentation
• Previous palliative care consultation notes if any
• Goals of care discussion documentation
• Performance status assessment (ECOG and/or Karnofsky)
• Prognosis documentation from treating oncologist

---

Step 1: Identify Patients Who Need Palliative Care Integration

ASCO/NCCN triggers for palliative care referral:

• Any patient with metastatic solid tumor at diagnosis
• Any patient with high symptom burden (ESAS total score ≥24 or any individual symptom ≥7/10)
• NCCN Distress Thermometer score ≥4/10
• Uncontrolled pain despite standard management
• Significant decline in performance status (ECOG ≥2 or drop of ≥1 point in 3 months)
• Hospitalization for symptom management or treatment complications
• Transition from active treatment to best supportive care
• Patient or family request for goals of care discussion
• Recurrent or progressive disease despite treatment
• Any hematologic malignancy with expected survival <2 years

Document the specific trigger(s) for palliative care consultation and the date identified.

---

Step 2: Conduct Comprehensive Symptom Assessment

Use validated tools for systematic symptom assessment:

Edmonton Symptom Assessment System (ESAS) — assess 0–10 for each:

1. Pain
2. Tiredness/Fatigue
3. Nausea
4. Depression
5. Anxiety
6. Drowsiness
7. Appetite
8. Wellbeing
9. Shortness of breath
10. Other (patient-identified)

Symptom management priorities by prevalence in advanced cancer:

Symptom	Prevalence	First-Line Approach
Pain	60–90%	WHO analgesic ladder; see managing-cancer-pain skill
Fatigue	60–90%	Exclude reversible causes (anemia, hypothyroid, depression); exercise prescription
Anorexia/Cachexia	50–80%	Nutritional counseling; megestrol acetate or dexamethasone for appetite stimulation
Dyspnea	30–70%	Opioids (low-dose morphine), fan therapy, supplemental O2 if hypoxic
Nausea	30–60%	Identify cause (medication, obstruction, CNS, metabolic); targeted antiemetics
Constipation	40–65%	Prophylactic bowel regimen with opioids; PEG-based laxatives first-line
Depression	20–45%	Screen with PHQ-9; antidepressants + psychotherapy referral
Delirium	20–40%	Identify and treat reversible causes; haloperidol for agitation if needed

---

Step 3: Integrate Palliative Care with Disease-Directed Therapy

Palliative care is concurrent with, not a replacement for, disease-directed therapy:

1. Symptom optimization enables treatment continuation — effective pain management and antiemetic support improve treatment adherence and reduce dose delays
2. Goals of care alignment — ensure the treatment plan reflects the patient's values and preferences; reassess at each disease milestone (progression, response, hospitalization)
3. Advance care planning — complete advance directive, identify healthcare proxy, consider POLST/MOLST for patients with advanced disease. Document specific preferences regarding: resuscitation, mechanical ventilation, artificial nutrition, hospitalization
4. Prognostic communication — ensure the patient has an accurate understanding of prognosis. Use frameworks like "Ask-Tell-Ask" or "SPIKES" protocol for delivering serious news
5. Care coordination — establish communication channels between oncology, palliative care, primary care, and home health. Designate a care coordinator for complex cases

---

Step 4: Document Palliative Care Metrics and Reassessment Plan

For each palliative care encounter, document:

1. Symptom scores (ESAS or equivalent) with comparison to prior assessment
2. Interventions initiated (medications, referrals, psychosocial support)
3. Goals of care discussion summary — what was discussed, who was present, decisions made
4. Advance care planning status and any changes to documented preferences
5. Performance status trajectory (stable, declining, improving)
6. Reassessment plan — next symptom assessment date, triggers for escalation
7. Hospice eligibility assessment — for patients with expected survival ≤6 months, document hospice discussion timing and patient/family readiness

---

Checkpoint B: Post-Draft Alignment (Mandatory)

1. Were validated symptom assessment tools (ESAS, Distress Thermometer) used rather than informal assessment?
2. Is palliative care documented as concurrent with disease-directed therapy (not positioned as giving up)?
3. Has advance care planning status been assessed and documented?
4. Are symptom scores tracked longitudinally with comparison to prior assessments?
5. Is the reassessment plan specific (date, responsible provider, escalation triggers)?

---

Quality Audit

• Palliative care referral trigger documented per ASCO/NCCN criteria
• ESAS or equivalent validated symptom assessment completed
• NCCN Distress Thermometer screening performed
• Each symptom rated ≥4/10 has a documented management plan
• Advance directive status documented (completed, in progress, declined, or not yet discussed)
• Healthcare proxy identified and documented
• Goals of care discussion documented with date and participants
• Prognostic understanding assessed and documented
• Psychosocial distress addressed (referral to social work, psychology, chaplaincy as needed)
• Caregiver needs assessed
• Palliative care positioned as concurrent care in documentation
• Hospice eligibility timeline assessed for patients with advanced disease
• Reassessment date and responsible provider specified
• Communication documented between oncology, palliative care, and primary care teams

---

Guidelines

• Palliative care is appropriate at any stage of cancer — not just end of life. Frame it as "an extra layer of support" when discussing with patients and families.
• Initiate palliative care consultation within 8 weeks of diagnosis for metastatic solid tumors per ASCO guidelines
• Symptom assessment should occur at every clinical encounter using the same validated tool for longitudinal tracking
• Never defer palliative care referral until "nothing more can be done" — this framing is outdated and harmful
• Goals of care discussions should be revisited at each major disease milestone: new diagnosis, progression, treatment change, hospitalization, decline in performance status
• Document advance care planning discussions even when the patient is not ready to complete documents — the process is iterative
• Palliative care consultation does not preclude clinical trial enrollment or aggressive disease-directed therapy
• Hospice eligibility (expected survival ≤6 months) should be assessed regularly — late hospice referral (<3 days before death) is a quality failure